Li C, Mori S, Li J, Kaji Y, Akiyama T, Kawanishi J, Norimatsu H
Department of Orthopedic Surgery, Kagawa Medical University, Kita-gun, Japan.
J Bone Miner Res. 2001 Mar;16(3):429-36. doi: 10.1359/jbmr.2001.16.3.429.
The aim of this study was to investigate the long-term effect of incadronate on fracture healing of the femoral shaft in rats. Female Sprague-Dawley 8-week-old rats were injected subcutaneously (sc) with either vehicle (V group) or two doses of incadronate (10 microg/kg and 100 microg/kg) three times a week for 2 weeks. Right femoral diaphysis was then fractured and fixed with intramedullary stainless wire. Just after fracture, incadronate treatment was stopped in pretreatment groups (P groups: P-10 and P-100) or continued in continuous treatment groups (C groups: C-10 and C-100). All rats were killed at 25 weeks or 49 weeks after surgery. Fractured femur was evaluated radiologically and mechanically and then stained in Villanueva bone stain and embedded in methyl methacrylate. Undecalcified cross-sections from the fracture area were evaluated microradiologically and histomorphometrically. Radiographic observation showed that the fracture line disappeared in all groups. Cross-sectional area in the C-100 group was the biggest among all groups and in the C-10 group was larger than that in the V group at 25 weeks. Histological and histomorphometric observations showed that the process of fracture healing was delayed under continuous treatment with incadronate as evidenced by the delay of both lamellar cortical shell formation and resolution of original cortex in C groups. Percent linear labeling perimeter, mineral apposition rate (MAR), and bone formation rate (BFR) in C groups significantly decreased compared with the other groups, indicating that the callus remodeling was suppressed under continuous treatment, especially with a high dose. Mechanical study showed that the stiffness and ultimate load of the fractured femur in the C 100 group were the highest among all groups at both 25 weeks and 49 weeks. In conclusion, this study showed that long-term continuous treatment with incadronate delayed the process of fracture healing of femur in rats, especially under high dose but it did not impair the recovery of mechanical integrity of the fracture.
本研究旨在探讨因卡膦酸盐对大鼠股骨干骨折愈合的长期影响。8周龄雌性斯普拉格-道利大鼠每周皮下注射3次溶剂(V组)或两种剂量的因卡膦酸盐(10微克/千克和100微克/千克),持续2周。然后将右侧股骨干骨折,并用髓内不锈钢丝固定。骨折后,预处理组(P组:P-10和P-100)停止因卡膦酸盐治疗,连续治疗组(C组:C-10和C-100)继续治疗。所有大鼠在术后25周或49周处死。对骨折的股骨进行放射学和力学评估,然后用维拉纽瓦骨染色剂染色,嵌入甲基丙烯酸甲酯。对骨折区域未脱钙的横截面进行微观放射学和组织形态计量学评估。放射学观察显示,所有组的骨折线均消失。在25周时,C-100组的横截面积在所有组中最大,C-10组的横截面积大于V组。组织学和组织形态计量学观察显示,因卡膦酸盐持续治疗会延迟骨折愈合过程,C组中板层皮质壳形成和原始皮质溶解的延迟即为证据。与其他组相比,C组的线性标记周长百分比、矿物质沉积率(MAR)和骨形成率(BFR)显著降低,表明连续治疗尤其是高剂量治疗会抑制骨痂重塑。力学研究表明,在25周和49周时,C-100组骨折股骨的刚度和极限载荷在所有组中最高。总之,本研究表明,长期连续使用因卡膦酸盐会延迟大鼠股骨骨折的愈合过程,尤其是高剂量时,但不会损害骨折力学完整性的恢复。